Top correlated features of the A-B, B-C, and A-C intervals before the introduction of the multidisciplinary team (MDT) on the left and after on the right. Point A is the time when the radiographic abnormality is first identified. Point B is when tissue diagnosis is established. Point C is when definitive treatment is started.

Table 1: Top correlated features of the A-B, B-C, and A-C intervals before the introduction of the multidisciplinary team (MDT) on the left and after on the right. Point A is the time when the radiographic abnormality is first identified. Point B is when tissue diagnosis is established. Point C is when definitive treatment is started.

Top Correlated Features for Each Time Interval
Pre-MDT		MDT
A-B Interval		A-B Interval
Primary Insurance: Medicare	0.138329	First Line Treatment Modality: Surgery	0.230753
Age at diagnosis	0.129978	Surgery as neoadjuvant, adjuvant, or monotherapy	0.216197
Primary Insurance: Geico No-Fault	0.098944	No surgery as neoadjuvant, adjuvant, or monotherapy	-0.216197
Primary Insurance: GHI	0.095892	Race, Ethnicity: Black or African American, Non-Hispanic or Latino	0.212675
Sex: Female	-0.094213	First Line Treatment by Department: In-house Surgery	0.193673
Sex: Male	0.094213	Retention Status: Not Retained	-0.148808
Primary Insurance: Managed Medicaid	-0.089142	Retention Status: Retained	0.148808
First Line Treatment Modality: Radiation	-0.072885	Living Status: Deceased at 6 months of initial contact	-0.12601
First Line Treatment by Department: In-house Radiation	-0.070447	Living Status: Alive at 6 months of initial contact	0.126006
Living Status: Deceased at 6 months of initial contact	0.068096	First Line Treatment by Department: External Surgery	0.121851
B-C Interval		B-C Interval
First Line Treatment by Department: External Medical Oncology	0.487673	First Line Treatment by Department: External Surgery	0.266607
Primary Insurance: GHI	0.347103	First Line Treatment by Department: In-house Surgery	-0.243417
First Line Treatment Modality: Chemotherapy	0.276782	Living Status: Deceased at 6 months of initial contact	-0.159619
First Line Treatment by Department: In-house Surgery	-0.213677	Living Status: Alive at 6 months of initial contact	0.159619
First Line Treatment Modality: Surgery	-0.205749	Not on hospice within 6 months of initial contact	0.155482
Age at diagnosis	0.19648	Hospice within 6 months of initial contact	-0.155482
Surgery as neoadjuvant, adjuvant, or monotherapy	-0.19593	First Line Treatment Modality: Sandostatin	0.149029
No surgery as neoadjuvant, adjuvant, or monotherapy	0.19593	First Line Treatment Modality: Surgery	-0.147716
Race, Ethnicity: White, Non-Hispanic or Latino	-0.186209	Race, Ethnicity: White, Hispanic or Latino	0.140701
Race, Ethnicity: Asian, Non-Hispanic or Latino	0.13013	First Line Treatment by Department: In-house Medical oncology	0.138439
A-C Interval		A-C Interval
Age at diagnosis	0.187696	Race, Ethnicity: Black or African American, Non-Hispanic or Latino	0.261471
Primary Insurance: GHI	0.173514	First Line Treatment by Department: External Surgery	0.197321
Primary Insurance: Geico No-Fault	0.130984	Living Status: Deceased at 6 months of initial contact	-0.159569
Primary Insurance: Managed Medicaid	-0.115292	Living Status: Alive at 6 months of initial contact	0.159569
Primary Insurance: Veterans Affairs Community Care Network	0.114047	Race, Ethnicity: White, Non-Hispanic or Latino	-0.147733
Primary Insurance: Medicare	0.109075	Primary Insurance: Managed Medicare	0.130578
Primary Insurance: United Healthcare	-0.070517	First Line Treatment Modality: Chemotherapy and Immunotherapy	-0.130343
Not on hospice within 6 months of initial contact	0.068017	Age at diagnosis	0.12144
Hospice within 6 months of initial contact	-0.068017	First Line Treatment by Department: In-house Medical Oncology	-0.119945
Sex: Female	-0.064429	Sex: Female	0.115196